Hi, thank you for the opportunity. Can you please expand a bit on the disruptions that you're noticing because of the Middle East conflict? In particular, how is it impacting your raw material sourcing across your regions and any outlook you would have that if the conflict stretches from here, can it materially impact your availability to procure your raw material?
Understood. Do you also have any ammonia needs in our domestic India manufacturing?
Thank you for the opportunity. My first question is, please, can you remind us how the soda ash domestic realizations in the U.S. are looking like for this year, because the contracts would have been signed in January. So, any colour on that would be useful?
Okay, that is useful. And can you please also make us understand how the cost would have changed in the last 5 years, because at the similar kind of realization s, we used to make very good margins pre-COVID times. So, now and then, on a shop level, how the cost structure has changed, so that we are not making any profit any more at these realizations. That will be helpful.
Thank you for the opportunity. My first question is on the litigation issue in Kenya. So, is it fair to assume that everything here is now settled and there are no further case complications that can arise out of this issue?
Understood, because I thought there is also a parallel re -approach that the local government body, they went to High Court again. So, does this judgment which has come into our favor by the court of appeal supersedes that High Court orders?
Thank you for the opportunity. My question is on the U.K. business , we saw that the margins have kind of improved sequentially, obviously, because of the product mix that has become favorable for now. But wanted to know your sense whether the current run rate is what something you expect to continue for the rest of the year? Or there is more room for improvement in terms of profitability and EBITDA that you deliver?
Okay. Any numbers that you can share how much of savings are you targeting from this in - house Q2 captive plant.
Obvious first two questions are, ca n you provide more details around what is the purpose of these NCDs? And also explain more on the non-cash charge, please?
So, when you say the write-down of this asset, is it the inventory or we need more clarity on that side?
Congratulations for a great set of numbers. I just wanted to continue from the previous question on propane. So while we understand that in the recent times, the propane is not allowed. But when the expectations are that Morbi is going to get bac k the production line? What is your sense? Is it going to be like a permanent shift to natural gas and propane not being allowed to Morbi even for the long term? Is that a supply shift that you are assuming or when things normalize, then they might get back and shift back to propane?
No, I wanted to get a sense because you are there closer to the industry. What is the inner circles indicating? Like government is serious about making a permanent shift to natural gas or things can go back to propane in the long-term point of view is what I'm asking.
My question is relating to your Nepal plant. Now that the plant is expected to get in commission in September, can you make some comments around how would your distribution strategy would be like? What kind of number of dealers are you looking to add? And some more color also on your marketing initiatives for that local market. That will be very helpful.
So, even now, do you have your ex clusive dealer partners in Nepal or is it sold more to multi- brand?
I'll make it quick in the interest of time, sorry. So, what I'm trying to understand is why there is so much variation in terms of your capex cost for setting up 1 MSM of capacity because it ranges from almost like INR10 crores per permission for the new plant acquisition that you have made just now. And it goes up to more than INR30 crores for the Nepal plant and some of the previous brownfield expansions that you have done, I think it translates to somewh ere about more than INR20 crores per MSM. So, I understand it could be different for different kind of products that we do, but what explains so much the variation in your capex cost? I wanted some clarity here.
But then comparing the, say, ROCEs for the new acquisitions that you have done, would the ROCEs be materially higher than wha t would you probably do at Nepal or some of your previous business? Or how do you see that?
Just speaking a couple of clarifications over here. When you talked about the LPG losses per cylinder as on now, you gave us 2 numbers, that is INR35 per cylinder and then you expect it to go up to INR100 to INR120. So what is the broad expectations in January, do you think it's going to be INR35 and this increased price would be applicable from February? That's my first question.
Okay. Understood. So running rate is about INR130?
Congratulations on a stupendous set of results. First thing I wanted to clarify on your ECL in Brazil. So how much is the total ECL in first half? Because there was some commentary about 1Q, you booked 13 million and then some of it got reversed. What is the total ECL in the first half for you?
So can you split it out into the first quarter and second quarter also? Just trying to understand how much was the amount in the second half because you also mentioned about some reversal that is where I'm coming from.
Yes. Thank you, gentlemen, for the opportunity. Good performance, I would say, in most of the businesses. I have a few questions relating to the recent industry developments. The first thing, recently, China has kind of been looking to introduce certain me asures in terms of trying to support the chemical prices, wherein they wish to take some old capacities out of the system. Given that you also have a fair presence in China, what would be your take on the situation? How do you see these measures - can they create a meaningful impact on the pricing? Any views on that would be helpful.
Can you share some more details over here, which products you are noticing price increase? And if possible, have you taken any price increases in any of your key molecules in China or globally?
Thank you so much for the opportunity. If you can give some more insights into your guidance. When you say a single digit growth guidance, so that kind of implies a broad range from 1% to 9%. Is there a possibility you can give a sense on whether it's going to be a mid-single digit or high single digit kind of guidance? That's my first question.
And when you say H2, do you mean by calendar year or it's going to be the Financial Year?